Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
As we mark International Clinical Trial Day today, Dr Seema Pai, President, ISC...
HAB Pharma and Signature Phytochemicals have completed a strategic merger throu...
The designation follows two randomised, controlled Phase III trials that showed ...
Helicons are stabilised, cell-penetrant alpha-helical peptides engineered to int...
Parexel, a leading global clinical development partner providing insights-drive...
Glenmark Pharmaceuticals USA announced the launch of Vancomycin Hydrochloride f...
Global pharma major, Lupin announced that it has received tentative approval fr...
Jascayd is said to be the first phosphodiesterase 4B (PDE4B) inhibitor with anti...
Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sci...
Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian...
Data from the DESTINY-Breast11 and DESTINY-Breast05 Phase III trials support the...
India’s personal care industry is undergoing a fundamental shift in how it thin...
As Aerolase expands in India, what is your strategy for enabling dermatology cl...
India is facing a perilous rise in counterfeit high-value medicines, from cance...
Dr. Reddy’s Laboratories, a global pharmaceutical company, announced the launch...
Your work leverages AI and machine learning to optimise CAR-T cell therapy. How...